CLINICAL TRIALS PROFILE FOR PHENAZINE
✉ Email this page to a colleague
All Clinical Trials for PHENAZINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02473042 ↗ | Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) | Active, not recruiting | M.D. Anderson Cancer Center | N/A | 2016-02-01 | The goal of this clinical research study is to learn if light electrical stimulation to the wrist area during surgery is feasible in women having breast surgery. |
NCT04852510 ↗ | Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin | Completed | Saudi German Hospital - Madinah | Phase 2/Phase 3 | 2019-02-01 | Objective: To investigate the potential benefit of adding Thymoquinone to Metformin in alleviating symptoms of polycystic ovarian syndrome. Methods: 207 overweight and obese PCOS Patients were divided into two groups. Patients in Group A, received Metformin 500 mg three times daily for 6 months. Patients in Group B, received a combination of Metformin 500 mg and Thymoquinone in the form of Black Cumin oil 500 mg capsules three times daily for 6 months. Follow up was done after 3 and 6 months from the beginning of the study for evaluation of menstrual cycle pattern, body mass index, Waist circumference, Hip circumference, and Waist / Hip ratio, Oral glucose tolerance test, Glycosylated Hemoglobin A1C, Superoxide dismutase activity and Malondialdehyde concentration. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PHENAZINE
Condition Name
Clinical Trial Locations for PHENAZINE
Trials by Country
Clinical Trial Progress for PHENAZINE
Clinical Trial Phase
Clinical Trial Sponsors for PHENAZINE
Sponsor Name